Vascular mechanisms of sepsis-induced cognitive dysfunction
脓毒症所致认知功能障碍的血管机制
基本信息
- 批准号:10681857
- 负责人:
- 金额:$ 72.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-15 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAffinity ChromatographyAnimal ModelAnimalsBinding ProteinsBiological MarkersBloodBlood - brain barrier anatomyBlood CirculationBlood VesselsBrainBrain InjuriesCause of DeathChronicCirculationClinical ResearchCognitiveCollaborationsCritical IllnessDataDementiaDevelopmentDextransElectrophysiology (science)Endothelial CellsEndotheliumExtravasationFaceFunctional disorderGlycobiologyGlycocalyxGlycosaminoglycansGoalsGrowth FactorHeparinHeparitin SulfateHippocampusHumanImpaired cognitionIndustrializationInfectionInterdisciplinary StudyInternationalJournalsLaboratoriesLearningLipopolysaccharidesLungManuscriptsMediatorMemoryMemory LossMethodsModelingMolecularMusNeurocognitiveOutcomePatientsPenetrationPrionsProteinsProteomicsPublishingRoleSepsisSocietiesSpecificityStreamSupportive careSurvivorsTestingTissuesUnited States National Academy of SciencesWorkblood damageblood-brain barrier permeabilizationclinical investigationcohorteffective therapyexperienceexperimental studyimprovedinjuredinnovationmortalitymultidisciplinaryneurobehaviornoveloverexpressionpatient populationpreventprospectiveresponsesepticseptic patientsspatial memorysugartherapeutic targettooltranslational impactuptake
项目摘要
Sepsis, the injurious systemic response to infection, is a major cause of death in both industrialized and
developing societies. With advances in supportive care, sepsis mortality has improved, leading to increased
recognition of the chronic consequences of this critical illness. Nearly 50% of sepsis survivors experience long-
term cognitive impairment, akin to accelerated dementia. Despite the substantial societal burden of septic
cognitive impairment, no effective therapies are known to prevent or treat this condition.
A multidisciplinary collaboration between the laboratories of Drs. Eric Schmidt (an expert in sepsis and vascular
glycobiology) and Paco Herson (an expert in brain injury) recently identified a novel mechanism underlying the
development of septic cognitive impairment. As detailed in manuscripts published in 2019 in the Journal of
Clinical Investigation and the Proceedings of the National Academy of Sciences, we observed that heparan
sulfate (HS) fragments, shed into the circulation during septic degradation of the endothelial glycocalyx,
specifically penetrate into only one tissue: the hippocampus, a compartment of the brain responsible for spatial
memory formation. Hippocampal-penetrating HS fragments sequester a key growth factor necessary for
learning, leading to persistent cognitive impairment in both septic animals and humans.
The striking hippocampal specificity of HS extravasation during sepsis prompted our laboratory to pursue
additional preliminary experiments using a murine lipopolysaccharide (LPS) model of sepsis. LPS-induced
hippocampal blood-brain barrier (BBB) hyperpermeability was specific to HS, as similarly-sized dextrans were
unable to penetrate the hippocampus. Heparin affinity chromatography and proteomic analyses identified that
LPS selectively induces several HS-binding proteins within the hippocampus, including an endothelial protein
previously implicated in paracellular BBB permeability (Prion related protein, Prp). This selective induction of
hippocampal HS-binding proteins mirrors the hippocampal specificity of HS extravasation during sepsis.
Based upon these preliminary data, we hypothesize that sepsis induces expression of HS-binding proteins
(such as Prp) released into the blood stream. These proteins facilitate the selective transport of
circulating HS into the hippocampus, leading to cognitive impairment in sepsis survivors. Pursuit of this
hypothesis will require mechanistic interrogation of sepsis-induced HS-binding proteins as putative mediators of
HS uptake by the hippocampal BBB. To achieve this goal requires a multi-disciplinary team to use cutting-edge
molecular tools to assess HS transport in animal models and clinical studies to correlate to the human patient
population. We will specifically identify 1) the mechanism of HS accumulation into the hippocampus, 2) the role
of circulating prion-related protein in neurocognitive dysfunction following experimental sepsis and 3) correlate
circulating HS and Prp with cognitive outcome in human sepsis patients
败血症,一种对感染的破坏性全身反应,是工业化和工业化国家死亡的主要原因
发展中社会。随着支持性护理的进步,脓毒症的死亡率有所改善,导致
认识到这一危重疾病的慢性后果。近50%的脓毒症幸存者经历了长期-
术语认知障碍,类似于加速痴呆症。尽管败血症带来了巨大的社会负担
认知障碍,目前还没有有效的治疗方法来预防或治疗这种疾病。
埃里克·施密特博士(败血症和血管方面的专家)的实验室之间的多学科合作
糖生物学)和帕科·赫森(脑损伤专家)最近发现了一种新的机制,
败血症认知功能障碍的发展。如2019年发表在《华尔街日报》上的手稿所述
临床研究和美国国家科学院院刊,我们观察到肝素
硫酸盐(HS)片段,在内皮糖催化剂败血症降解过程中进入循环,
特定地只穿透到一种组织:海马体,这是大脑中负责空间分布的一个隔间
记忆的形成。贯穿海马区的HS片段隔离了一个关键的生长因子
学习,导致败血症动物和人类的持续性认知障碍。
脓毒症时HS渗出的显著海马区特异性促使我们实验室研究
使用小鼠脂多糖(LPS)脓毒症模型进行的其他初步实验。内毒素诱导
海马血脑屏障(BBB)的高通透性是HS所特有的,与类似大小的右旋糖苷一样
无法穿透海马体。肝素亲和层析和蛋白质组学分析证实
内毒素选择性地诱导海马区内的几种HS结合蛋白,包括一种内皮蛋白
先前与细胞旁血脑屏障通透性有关(Prion相关蛋白,PRP)。这种选择性的诱导
海马区HS结合蛋白反映了败血症时HS渗出的海马区特异性。
根据这些初步数据,我们假设败血症诱导HS结合蛋白的表达
(如PRP)释放到血液中。这些蛋白质有助于选择性地转运
将HS循环到海马体,导致败血症幸存者的认知障碍。追求这一点
假说将需要对脓毒症诱导的HS结合蛋白作为假定的介体进行机械性询问
海马区BBB对HS的摄取。要实现这一目标,需要一支多学科的团队来使用尖端技术
评估HS在动物模型和临床研究中转运的分子工具与人类患者的相关性
人口。我们将具体确定1)HS在海马区蓄积的机制,2)作用
实验性脓毒症后神经认知功能障碍患者循环蛋白的变化及其相关性
人类脓毒症患者循环HS和PRP与认知结局的关系
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paco S Herson其他文献
Paco S Herson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paco S Herson', 18)}}的其他基金
New approach to sustained neuroprotection and enhanced recovery following acute ischemic stroke
急性缺血性中风后持续神经保护和促进康复的新方法
- 批准号:
10584833 - 财政年份:2022
- 资助金额:
$ 72.7万 - 项目类别:
Targeting circulating endothelial glycocalyx fragments to reduce septic encephalopathy
靶向循环内皮糖萼片段以减少脓毒性脑病
- 批准号:
9922971 - 财政年份:2017
- 资助金额:
$ 72.7万 - 项目类别:
Targeting TRPM2 channels to improve synaptic and cognitive function after cerebral ischemia
靶向TRPM2通道改善脑缺血后的突触和认知功能
- 批准号:
9203070 - 财政年份:2016
- 资助金额:
$ 72.7万 - 项目类别:
Bead-Based Approach for Combined Mechanical and Pharmacological Treatment of Acut
基于珠子的急性急性机械和药物联合治疗方法
- 批准号:
8742017 - 财政年份:2013
- 资助金额:
$ 72.7万 - 项目类别:
Bead-Based Approach for Combined Mechanical and Pharmacological Treatment of Acut
基于珠子的急性急性机械和药物联合治疗方法
- 批准号:
8637561 - 财政年份:2013
- 资助金额:
$ 72.7万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7370188 - 财政年份:2007
- 资助金额:
$ 72.7万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7616219 - 财政年份:2007
- 资助金额:
$ 72.7万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
8103597 - 财政年份:2007
- 资助金额:
$ 72.7万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7501939 - 财政年份:2007
- 资助金额:
$ 72.7万 - 项目类别:
GABA-A Receptor Rescue as a Neuroprotective Strategy in Cerebral Ischemia
GABA-A 受体拯救作为脑缺血的神经保护策略
- 批准号:
7846096 - 财政年份:2007
- 资助金额:
$ 72.7万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 72.7万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 72.7万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 72.7万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 72.7万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 72.7万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 72.7万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 72.7万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 72.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 72.7万 - 项目类别:
Collaborative Research and Development Grants